Blockade of PD-L1/PD-1 signaling promotes osteo-/odontogenic differentiation through Ras activation

Abstract

The programmed cell death ligand 1 (PD-L1) and its receptor programmed cell death 1 (PD-1) deliver inhibitory signals to regulate immunological tolerance during immune-mediated diseases. However, the role of PD-1 signaling and its blockade effect on human dental pulp stem cells (hDPSCs) differentiation into the osteo-/odontogenic lineage remain unknown. We show here that PD-L1 expression, but not PD-1, is downregulated during osteo-/odontogenic differentiation of hDPSCs. Importantly, PD-L1/PD-1 signaling has been shown to negatively regulate the osteo-/odontogenic differentiation of hDPSCs. Mechanistically, depletion of either PD-L1 or PD-1 expression increased ERK and AKT phosphorylation levels through the upregulation of Ras enzyme activity, which plays a pivotal role during hDPSCs osteo-/odontogenic differentiation. Treatment with nivolumab (a human anti-PD-1 monoclonal antibody), which targets PD-1 to prevent PD-L1 binding, successfully enhanced osteo-/odontogenic differentiation of hDPSCs through enhanced Ras activity-mediated phosphorylation of ERK and AKT. Our findings underscore that downregulation of PD-L1 expression accompanies during osteo-/odontogenic differentiation, and hDPSCs-intrinsic PD-1 signaling inhibits osteo-/odontogenic differentiation. These findings provide a significant basis that PD-1 blockade could be effective immunotherapeutic strategies in hDPSCs-mediated dental pulp regeneration.

References

[1] Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl Acad. Sci. USA, 2000, 97: 13625-13630.

[2] Zhang W, Walboomers XF, Shi S, Fan M, Jansen JA. Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. Tissue Eng., 2006, 12: 2813-2823.

[3] Gronthos S, . Stem cell properties of human dental pulp stem cells. J. Dent. Res., 2002, 81: 531-535.

[4] Batouli S, . Comparison of stem-cell-mediated osteogenesis and dentinogenesis. J. Dent. Res., 2003, 82: 976-981.

[5] Matsui M, Kobayashi T, Tsutsui TW. CD146 positive human dental pulp stem cells promote regeneration of dentin/pulp-like structures. Hum. Cell, 2018, 31: 127-138.

[6] Prescott RS, . In vivo generation of dental pulp-like tissue by using dental pulp stem cells, a collagen scaffold, and dentin matrix protein 1 after subcutaneous transplantation in mice. J. Endod., 2008, 34: 421-426.

[7] Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol., 2018, 18: 153-167.

[8] Boussiotis VA. Molecular and biochemical aspects of the PD-1 checkpoint pathway. N. Engl. J. Med., 2016, 375: 1767-1778.

[9] Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell, 2017, 168: 707-723.

[10] Ferris RL, . Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 2016, 375: 1856-1867.

[11] Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell, 2015, 27: 450-461.

[12] Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu. Rev. Med., 2014, 65: 185-202.

[13] Alsaab HO, . PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front. Pharm., 2017, 8: 561.

[14] Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol., 2008, 9: 517-531.

[15] Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell, 2017, 170: 17-33.

[16] Prior IA, Hancock JF. Ras trafficking, localization and compartmentalized signalling. Semin. Cell Dev. Biol., 2012, 23: 145-153.

[17] Jeon SM, Lim JS, Kim HR, Lee JH. PFK activation is essential for the odontogenic differentiation of human dental pulp stem cells. Biochem. Biophys. Res. Commun., 2021, 544: 52-59.

[18] Quevedo CE, . Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment. Nat. Commun., 2018, 9

[19] Cruz-Migoni A, . Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Proc. Natl Acad. Sci. USA, 2019, 116: 2545-2550.

[20] Miura M, . SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl Acad. Sci. USA, 2003, 100: 5807-5812.

[21] Seo BM, . Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet, 2004, 364: 149-155.

[22] Zhang Q, . Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J. Immunol., 2009, 183: 7787-7798.

[23] Sonoyama W, . Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J. Endod., 2008, 34: 166-171.

[24] Morsczeck C, . Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol., 2005, 24: 155-165.

[25] Mayo V, Sawatari Y, Huang CY, Garcia-Godoy F. Neural crest-derived dental stem cells—where we are and where we are going. J. Dent., 2014, 42: 1043-1051.

[26] Lan X, Sun Z, Chu C, Boltze J, Li S. Dentalpulp stem cells: an attractive alternative for cell therapy in ischemic stroke. Front. Neurol., 2019, 10: 824.

[27] Jin Q, . Comparative characterization of mesenchymal stem cells from human dental pulp and adipose tissue for bone regeneration potential. Artif. Cells Nanomed. Biotechnol., 2019, 47: 1577-1584.

[28] Wada N, Menicanin D, Shi S, Bartold PM, Gronthos S. Immunomodulatory properties of human periodontal ligament stem cells. J. Cell Physiol., 2009, 219: 667-676.

[29] Pierdomenico L, . Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation, 2005, 80: 836-842.

[30] Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells, 2017, 35: 766-776.

[31] Kleffel S, . Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth. Cell, 2015, 162: 1242-1256.

[32] Du S, . Blockade of tumor-expressed PD-1 promotes lung cancer growth. Oncoimmunology, 2018, 7: e1408747.

[33] Wang X, . Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy. Proc. Natl Acad. Sci. USA, 2020, 117: 6640-6650.

[34] Chen L, . Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells. Investig. Ophthalmol. Vis. Sci., 2009, 50: 4941-4948.

[35] Liu Y, . PD-1 is required to maintain stem cell properties in human dental pulp stem cells. Cell Death Differ., 2018, 25: 1350-1360.

[36] Patsoukis N, . Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci. Signal., 2012, 5: ra46.

[37] Liotti F, . PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells. J. Exp. Clin. Cancer Res., 2021, 40: 22.

[38] Bunda S, . Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis. Nat. Commun., 2015, 6

[39] Ran H, Tsutsumi R, Araki T, Neel BG. Sticking It to Cancer with Molecular Glue for SHP2. Cancer Cell, 2016, 30: 194-196.

[40] Liu J, . Concise reviews: characteristics and potential applications of human dental tissue-derived mesenchymal stem cells. Stem Cells, 2015, 33: 627-638.

[41] Wang X, . Comparative characterization of stem cells from human exfoliated deciduous teeth and dental pulp stem cells. Arch. Oral Biol., 2012, 57: 1231-1240.

[42] Wang H, . Comparative characterization of SHED and DPSCs during extended cultivation in vitro. Mol. Med. Rep., 2018, 17: 6551-6559.

[43] Xiang Z, . Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways. Oncogene, 2021, 40: 5002-5012.

[44] Liu R, . Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. Mol. Cell, 2021, 81: 2722-2735 e2729.

Funding

National Research Foundation of Korea (NRF)(2020R1C1C1011350)